• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The postoperative pharmacokinetics of codeine.

作者信息

Persson K, Hammarlund-Udenaes M, Mortimer O, Rane A

机构信息

Division of Clinical Pharmacology, Akademiska Sjukhuset, University of Uppsala, Sweden.

出版信息

Eur J Clin Pharmacol. 1992;42(6):663-6. doi: 10.1007/BF00265933.

DOI:10.1007/BF00265933
PMID:1623909
Abstract

The metabolism and systemic availability of codeine have been studied in 12 patients after cholecystectomy. They were given 20 mg codeine as an IV bolus dose on the first day after surgery and 50 mg codeine as a single oral on the fourth day after surgery. Codeine had a medium to high extraction ratio and a total plasma clearance of 10.8 (4.3) ml.min-1.kg-1. The clearance varied four-fold between subjects. All the patients were extensive metabolizers with regard to the debrisoquine/sparteine polymorphism, as tested using dextromethorphan as the probe drug. Nevertheless, the formation of morphine from codeine was very small and plasma morphine concentrations were below the detection limit of 3.3 nmol.l-1 (1 ng.ml-1). As a corollary, the morphine/codeine ratio in the the concentration-time curves was less than 3% in all the patients. The systemic availability of codeine varied extensively between subjects (range 12-84%). This might partly explain differences in the dose of codeine required as an analgesic.

摘要

相似文献

1
The postoperative pharmacokinetics of codeine.
Eur J Clin Pharmacol. 1992;42(6):663-6. doi: 10.1007/BF00265933.
2
Codeine in post-operative pain. Study of the influence of sparteine phenotype and serum concentrations of morphine and morphine-6-glucuronide.可待因用于术后疼痛。关于司巴丁表型以及吗啡和吗啡-6-葡萄糖醛酸血清浓度影响的研究。
Eur J Clin Pharmacol. 1998 Aug;54(6):451-4. doi: 10.1007/s002280050491.
3
On the assessment of drug metabolism by assays of codeine and its main metabolites.通过可待因及其主要代谢物的测定评估药物代谢
Ther Drug Monit. 2000 Jun;22(3):258-65. doi: 10.1097/00007691-200006000-00005.
4
Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.
Clin Pharmacol Ther. 1990 Dec;48(6):686-93. doi: 10.1038/clpt.1990.212.
5
Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake.可待因摄入后奎尼丁对可待因和吗啡血浆及脑脊液浓度的影响。
Eur J Clin Pharmacol. 1996;49(6):503-9. doi: 10.1007/BF00195938.
6
Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.右美沙芬代谢能力差和代谢能力强的个体中可待因向吗啡的多晶型转化:与免疫鉴定的细胞色素P - 450IID1存在的关系。
Clin Pharmacol Ther. 1990 Jan;47(1):27-35. doi: 10.1038/clpt.1990.4.
7
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.司巴丁广泛代谢者和慢代谢者中可待因与吗啡的药代动力学、镇痛效果及副作用
Eur J Clin Pharmacol. 1996;51(3-4):289-95. doi: 10.1007/s002280050200.
8
Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.由于CYP2D6基因重复导致的超快速代谢者中可待因及其代谢产物吗啡的药代动力学
Pharmacogenomics J. 2007 Aug;7(4):257-65. doi: 10.1038/sj.tpj.6500406. Epub 2006 Jul 4.
9
Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan.右美沙芬十名广泛代谢者和一名慢代谢者使用可待因患者自控镇痛用于术后镇痛。
Br J Clin Pharmacol. 1995 Feb;39(2):182-6. doi: 10.1111/j.1365-2125.1995.tb04428.x.
10
Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.一名慢代谢者和七名快代谢者单次及长期服用可待因后的处置与代谢情况。
Br J Clin Pharmacol. 1991 Apr;31(4):381-90. doi: 10.1111/j.1365-2125.1991.tb05550.x.

引用本文的文献

1
Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of codeine in different CYP2D6 phenotypes.基于生理的药代动力学建模以预测不同CYP2D6表型中可待因的药代动力学。
Front Pharmacol. 2024 May 2;15:1342515. doi: 10.3389/fphar.2024.1342515. eCollection 2024.
2
A Novel Maintenance Therapeutic for Opioid Use Disorder.一种新型阿片类药物使用障碍维持治疗药物。
J Pharmacol Exp Ther. 2021 Aug;378(2):133-145. doi: 10.1124/jpet.120.000214. Epub 2021 May 19.
3
Recent advances in the use of opioids for cancer pain.阿片类药物在癌症疼痛治疗中的最新进展。

本文引用的文献

1
Comparative potencies of codeine and its demethylated metabolites after intraventricular injection in the mouse.
J Pharmacol Exp Ther. 1963 May;140:155-61.
2
Analgesic potency of normorphine in patients with postoperative pain.
J Pharmacol Exp Ther. 1958 Nov;124(3):260-3.
3
The effect of N-demethylation on certain pharmacologic actions of morphine, codeine, and meperidine in the mouse.N-去甲基化对小鼠体内吗啡、可待因和哌替啶某些药理作用的影响。
J Pharmacol Exp Ther. 1954 Oct;112(2):191-6.
4
J Pain Res. 2009 Sep 23;2:135-55. doi: 10.2147/jpr.s6905.
4
The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers.二氢可待因及其代谢产物二氢吗啡的内脏和躯体抗伤害感受作用。一项针对广泛代谢者和奎尼丁诱导的慢代谢者的交叉研究。
Br J Clin Pharmacol. 1998 Jun;45(6):575-81. doi: 10.1046/j.1365-2125.1998.00727.x.
5
Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide.可待因及可待因6-葡萄糖醛酸苷的镇痛和免疫调节作用。
Pharm Res. 1996 Feb;13(2):296-300. doi: 10.1023/a:1016059618633.
6
Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery.
Eur J Clin Pharmacol. 1993;44(4):319-23. doi: 10.1007/BF00316466.
7
Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan.右美沙芬十名广泛代谢者和一名慢代谢者使用可待因患者自控镇痛用于术后镇痛。
Br J Clin Pharmacol. 1995 Feb;39(2):182-6. doi: 10.1111/j.1365-2125.1995.tb04428.x.
Codeine disposition in smokers and nonsmokers.可待因在吸烟者和非吸烟者体内的代谢情况。
Clin Pharmacol Ther. 1982 Aug;32(2):218-27. doi: 10.1038/clpt.1982.151.
5
Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.
Clin Pharmacokinet. 1982 May-Jun;7(3):266-79. doi: 10.2165/00003088-198207030-00006.
6
Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.右美沙芬作为去甲丙咪嗪羟化多态性的安全探针。
Lancet. 1984 Sep 1;2(8401):517-8. doi: 10.1016/s0140-6736(84)92591-1.
7
Species differences in plasma protein binding of morphine and codeine.吗啡和可待因血浆蛋白结合的种属差异。
Am J Vet Res. 1973 Apr;34(4):571-4.
8
Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.多态性右美沙芬代谢:氧化O-去甲基化与异喹胍羟基化的共分离。
Clin Pharmacol Ther. 1985 Dec;38(6):618-24. doi: 10.1038/clpt.1985.235.
9
Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration.
Eur J Clin Pharmacol. 1986;30(6):673-7. doi: 10.1007/BF00608214.
10
Comparative disposition of codeine and pholcodine in man after single oral doses.单次口服给药后可待因和福尔可定在人体内的比较处置情况。
Br J Clin Pharmacol. 1986 Jul;22(1):61-71. doi: 10.1111/j.1365-2125.1986.tb02881.x.